Latest News

• share
• favorite_border

A new study by researchers at UCSF Benioff Children’s Hospitals and St. Jude Children’s Research Hospital has identified what they believe to be a key reason behind patients’ treatment-resistance in the rare inflammatory disorder HLH. The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.

• share
• favorite_border

Survival may more than double for adults with glioblastoma, the most common and deadly type of brain tumor, if neurosurgeons remove the surrounding tissue as aggressively as they remove the cancerous core of the tumor.  This discovery, reported in a retrospective study headed by researchers at UC San Francisco, is welcome news for those in the glioblastoma community, which celebrated its last breakthrough in 2005 with the introduction of the chemotherapy drug temozolomide.

• share
• favorite_border

Pelvic examinations and cervical cancer screenings are no longer recommended for most females under age 21 during routine health visits, but a new study has found that millions of young women are unnecessarily undergoing the tests, which can lead to false-positive testing, over-treatment, anxiety and needless cost.  Researchers at UC San Francisco and the Centers for Disease Control and Prevention (CDC) estimated that 1.

• share
• favorite_border

JUUL delivers substantially more nicotine to the blood per puff than cigarettes or previous-generation e-cigarettes (e-cigs) and impairs blood vessel function comparable to cigarette smoke, according to a new study by researchers at UC San Francisco.  The study, which appears online Jan. 4, 2019, in Tobacco Regulatory Science, found that nicotine concentrations were five to eight times higher in rodents that were exposed to JUUL versus other tobacco products.

• share
• favorite_border

Glioblastomas are the most aggressive form of brain cancer - they grow and spread rapidly through the brain and are virtually impossible to eradicate, typically leading to death within one or two years of diagnosis. Scientists are constantly seeking more powerful targeted therapies, but so far without success — in part because glioblastomas are challenging to study in a laboratory setting.

• share
• favorite_border

• share
• favorite_border

UC San Francisco announced Thursday it will establish the UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff.

• share
• favorite_border

Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase in both the U.S. and Ontario, Canada, according to a new study of more than 135 million imaging exams conducted by researchers at UC Davis, UC San Francisco and Kaiser Permanente.

• share
• favorite_border

Earlier this month, Nina Shah, MD, joined other myeloma patients, caregivers, and clinical providers on a three-day trek across Iceland’s spectacular landscape.

• share
• favorite_border

Skin cancer can strike anyone — and exposure to the sun’s ultraviolet rays is a leading risk factor.

• share
• favorite_border

UCSF Medical Center has been recognized among the nation’s elite hospitals in U.S. News & World Report’s 2019-2020 Best Hospitals survey, marking the 21st year that UCSF Health has been listed among the top 10 hospitals in the prestigious listings and best in Northern California.

• share
• favorite_border

Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and UC San Francisco, have discovered an autoimmune disease that appears to affect men with testicular cancer.

• share
• favorite_border

Use of medical imaging during pregnancy increased significantly in the United States, a new study has found, with nearly a four-fold rise over the last two decades in the number of women undergoing computed tomography CT scans, which expose mothers and fetuses to radiation. Pregnant women are warned to minimize radiation exposure.

• share
• favorite_border

The new UCSF Bakar Precision Cancer Medicine Building opened late June in Mission Bay. The treatments, technologies, and models of care offered to patients in this new space will reflect the most current thinking in how to tailor treatment to individual patients based on unique and defining characteristics of their tumors, personal genetics, and lifestyle.

• share
• favorite_border

In late June, UC San Francisco opened the Bakar Precision Cancer Medicine Building, a pioneering cancer center devoted to providing adult patients with highly advanced treatments, including immunotherapy, genetic counseling, molecular profiling of tumors, fully integrated clinical trials, and advanced imaging.

• share
• favorite_border

Signaling its continued commitment to pioneering research, UC San Francisco has appointed Rohit Gupta as its inaugural Chief Biobank Officer (CBO). His appointment, which follows a national search, is effective June 19.

• share
• favorite_border

Wearing red ribbons in honor of their mentor Dr. Arti Hurria, Drs. Li-Wen Huang and Melisa Wong of the UCSF Older Adult Cancer Care Program discuss the emerging field of geriatric oncology research. Mentorship within a close-knit community is driving interest in the field of geriatric oncology. Dr. Li-Wen Huang, Hematology Oncology Fellow, and Dr.

• share
• favorite_border

Jennifer Doudna, PhD, and Jonathan Weissman, PhD. Photo by Barbara Ries GlaxoSmithKline plc (GSK) has launched a five-year, $67 million collaboration with the San Francisco and Berkeley campuses of the University of California to build a state-of-the-art laboratory that will use CRISPR technologies to explore how genes cause disease and to rapidly accelerate the discovery of new medicines.

• share
• favorite_border

This week, Luke Gilbert, PhD, Assistant Professor, Department of Urology, and a Goldberg-Benioff Endowed Professor in Prostate Cancer Translational Biology, was named a member of the 2019 class of the Pew-Stewart Scholars Program for Cancer Research. Gilbert was one of seven early-career scientists working in the US to garner the award.

• share
• favorite_border

Dr. Lawrence Fong, leader of the HDFCCC Cancer Immunotherapy Program, was featured last month on the CureTalks podcast for a live discussion of the latest in cancer immunotherapy research, clinical trials, and treatments. Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Several types of immunotherapy are used to treat cancer.